The Effect of Empagliflozin on Myocardial Extracellular Matrix Expansion in Patients With Type 2 Diabetes and Coronary Artery Disease

CIRCULATION(2019)

引用 1|浏览21
暂无评分
摘要
Introduction: Sodium glucose cotransporter 2 (SGLT2) inhibitors reduce cardiovascular (CV) mortality, heart failure hospitalization, and promote left ventricular (LV) remodeling in patients with ty...
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要